Our Story
Established in 2022, by pharmaceutical experts with over 30 years of industry experience, Hybsa Consulting Limited (“HYBSA”) assists pharmaceutical developers and manufacturers from across the globe enter the European markets
HYBSA is a trusted partner for business development and commercial services, working with firms from Australia, China, Europe, India, and the USA
HYBSA has a strong and broad network of skilled professionals from different disciplines within market access that we work with to undertake assignments on behalf of clients
HYBSA is a trusted partner for business development and commercial services, working with firms from Australia, China, Europe, India, and the USA
HYBSA has a strong and broad network of skilled professionals from different disciplines within market access that we work with to undertake assignments on behalf of clients
Our Founder
Ahmed Al- Derzi has over 30 years of pharmaceutical industry experience in Generics; Value Added Medicines (VAMs); Repurposed Medicines; and Orphan Medicines covering every therapeutic area and pharmaceutical form. Ahmed is a serial business developer and entrepreneur having started two commercialisation companies in Europe, namely: Consilient Health Ltd (where he led the Planning and BD efforts as a Co-Founder for the initial 7 years from formation and subsequently ran the business for 11 years as CEO) and Oranda Therapeutics Ltd (where he holds the position of Co-Founder and CEO). He has also been actively supporting Plexus Ventures LLC (since late 2022) on a multitude of M&A; Licensing Out; and Market Research assignments that he helped procure for the firm.
Ahmed is Chartered Chemist and sat on the Boards of Medicines for Europe and the British Generic Manufacturers Association from 2006 to 2022.
Through Ahmed’s wide and international professional networks, Hybsa is able to tap the relevant talents and expertise to ensure an efficient and cost-effective service for all clients.
"We pride ourselves on delivering excellent service at competitive rates. We specialise in serving family owned SMEs and entrepreneurs achieve their objectives in the EU markets."